Related Experiment Video
Updated: Jun 24, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Provincial variability in congenital heart disease prevalence in Argentina, 2014-2019: A population-based analysis
María Clara Vita1, Nicolás Fantozzi1, Federico Méndez Ortiz1
1Hospital General de Niños Pedro de Elizalde, Buenos Aires, Argentina.
Insights
Congenital heart defects (CHDs) show significant regional disparities in prevalence and diagnosis timing across Argentina. Improving early detection and equitable access to care is vital for reducing infant mortality.
Area of Science:
- Pediatrics
- Cardiology
- Public Health
Background:
- Congenital heart defects (CHDs) are a major cause of infant mortality globally.
- Timely diagnosis and treatment are critical for improving outcomes in neonates with CHDs.
- Unequal access to specialized care exists in Argentina, impacting early detection rates.
Purpose of the Study:
- To determine the prevalence and diagnosis timing of CHDs and critical CHDs (cCHDs) in live births within Argentina's public health system.
- To identify geographic disparities in CHD prevalence and diagnostic timeliness across Argentine provinces.
Main Methods:
- A cross-sectional, descriptive study utilizing aggregated, province-level data from the National Registry of Congenital Heart Diseases.
- Analysis included live births between 2014-2019 diagnosed with CHDs up to five years of age.
- Prevalence rates and median age at notification were calculated per province.
Main Results:
- Over 2.4 million live births yielded 16,150 CHDs (65.3/10,000) and 3,700 cCHDs (15.0/10,000).
- Significant provincial variation observed: CHD prevalence ranged from 34.9 to 212.2/10,000; cCHD prevalence from 10.7 to 27.3/10,000.
- National median age at notification was 75 days for CHDs and 29 days for cCHDs, with notable provincial differences.
Conclusions:
- Substantial provincial variability exists in both CHD prevalence and the timeliness of diagnosis reporting in Argentina.
- Addressing these geographic disparities is essential for improving early detection and specialized care access.
- Strengthening public health strategies for CHD management can reduce neonatal morbidity and mortality.
Abstract:
Congenital heart defects are a leading cause of neonatal morbidity and mortality worldwide. Early diagnosis is essential to enable timely treatment and improve patient outcomes; however, access to early detection and specialized care is unevenly distributed across regions in Argentina. This study describes the prevalence and timing of diagnosis of congenital heart defects and critical congenital heart defects among live births covered by the public health system nationwide. We performed a cross-sectional, descriptive study based on province-level aggregated data. The analysis included all live births between 2014 and 2019 with a diagnosis of congenital heart defects reported up to five years of age in the National Registry of Congenital Heart Diseases. We calculated prevalence rates and median age at case notification for each province to assess geographic disparities. Out of 2,473,720 live births, 16,150 cases of congenital heart defects (prevalence 65.3 per 10,000 live births) and 3,700 cases of critical congenital heart defects (15.0 per 10,000) were identified. Provincial prevalence ranged widely, from 34.9 to 212.2 per 10,000 for congenital heart defects and from 10.7 to 27.3 per 10,000 for critical cases. The national median age at notification was 75 days for all congenital heart defects and 29 days for critical cases, with notable provincial differences. These findings demonstrate significant provincial variability in both the prevalence of congenital heart defects and the age at which cases are reported to the national health registry. Strengthening early detection efforts and ensuring equitable access to specialized care are crucial to reduce morbidity and mortality associated with these conditions in Argentina and similar settings.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Bias in Epidemiological Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease II: Pathophysiology

